Color Vision Tied to Bladder Survival - Report - MDSpire

Color Vision Tied to Bladder Survival

  • By

  • Kerri Miller

  • March 10, 2026

  • 5 min

Share

Clinical Report: Color Vision Tied to Bladder Survival

Overview

Revise to specify the source of the 52% mortality risk and ensure it is accurately represented.

Background

Color vision deficiency is a common inherited disorder, affecting a significant portion of the male population. Its potential impact on cancer detection and survival outcomes is critical, particularly for cancers like bladder cancer where visible symptoms may be misinterpreted. Understanding the implications of CVD in cancer patients can inform screening and diagnostic strategies.

Data Highlights

Verify and update the table to ensure it accurately reflects the study's findings.

Key Findings

  • Patients with bladder cancer and CVD had a 52% higher 20-year mortality risk.
  • Overall survival was lower in bladder cancer patients with CVD compared to those without.
  • No significant survival difference was observed in colorectal cancer patients based on color vision status.
  • Color vision deficiency may lead to delayed recognition of symptoms like blood in urine, impacting timely diagnosis.
  • Screening practices may mitigate the effects of CVD on cancer detection.

Clinical Implications

Healthcare providers should be aware of the potential for color vision deficiency to affect cancer detection and patient outcomes, particularly in bladder cancer. Enhanced screening and patient education may be necessary to address these challenges.

Conclusion

The findings suggest a significant association between color vision deficiency and survival outcomes in bladder cancer, warranting further investigation into screening and diagnostic practices for affected patients.

References

  1. Fattah et al., Nature Health, 2025 -- Impact of colour vision deficiency on bladder and colorectal cancer survival
  2. The ASCO Post, 2026 -- Can Color Vision Deficiency Impact Survival in Bladder or Colorectal Cancer?
  3. The ASCO Post, 2026 -- Timely Scans May Reduce Mortality in Patients Who Present to the ER With Hematuria
  4. The ASCO Post — Timely Scans May Reduce Mortality in Patients Who Present to the ER With Hematuria
  5. The ASCO Post — Timely Scans May Reduce Mortality in Patients Who Present to the ER With Hematuria
  6. EAU Guidelines on Non-muscle-invasive Bladder Cancer 2025
  7. Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer
  8. Impact of colour vision deficiency on bladder and colorectal cancer survival | Nature Health

Original Source(s)

Related Content